- Previous Close
0.7750 - Open
0.7550 - Bid 0.7500 x --
- Ask 0.8000 x --
- Day's Range
0.7500 - 0.7870 - 52 Week Range
0.0108 - 1.3500 - Volume
2,638,529 - Avg. Volume
535,092 - Market Cap (intraday)
1.389M - Beta (5Y Monthly) 0.27
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1500 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Metir plc manufactures and sells equipment used monitoring water for toxins and pathogens in the United Kingdom, the United States, Europe, China, and internationally. The company provides MiD platform solutions for MS detection, including 4500 MiD; MiDas, a compact sampling interface that allows automated sampling, dilution, and injection for direct MS analysis; and MiD Protein ID, a miniaturised mass spectrometer, as well as consumables and spare parts. It also offers SPE-LC-MS that extracts and analyze low concentration samples; and Microtox reagent consumables that is used for monitoring water for toxins and pathogens. In addition, the company provides product support services and consultancy services, as well as laboratory, engineering, and monitoring services to various industries, including environment, biopharma, pharmaceutical, personal care, food and drink, and academia. It sells its products through OEMs and distribution sales channels. The company was formerly known as Microsaic Systems plc and changed its name to Metir plc in February 2025. Metir plc was incorporated in 1998 and is based in York, the United Kingdom.
www.metirplc.com2
Full Time Employees
December 31
Fiscal Year Ends
Sector
Scientific & Technical Instruments
Industry
Recent News: MET.L
View MorePerformance Overview: MET.L
Trailing total returns as of 3/14/2025, which may include dividends or other distributions. Benchmark is FTSE 100 .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MET.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MET.L
View MoreValuation Measures
Market Cap
1.39M
Enterprise Value
424.63k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.11
Price/Book (mrq)
0.95
Enterprise Value/Revenue
0.70
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-62.98%
Return on Equity (ttm)
-132.68%
Revenue (ttm)
608k
Net Income Avi to Common (ttm)
-2.06M
Diluted EPS (ttm)
-0.1500
Balance Sheet and Cash Flow
Total Cash (mrq)
982k
Total Debt/Equity (mrq)
1.24%
Levered Free Cash Flow (ttm)
-565.68k